Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: fiard g. World J Urol. 2023 Jan;41(1):77-84. doi: 10.1007/s00345-022-04244-4. Epub 2022 Dec 12. World J Urol. 2023. PMID: 36509932
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions.
Stavrinides V, Eksi E, Finn R, Texeira-Mendes L, Rana S, Trahearn N, Grey A, Giganti F, Huet E, Fiard G, Freeman A, Haider A, Allen C, Kirkham A, Cole AP, Collins T, Pendse D, Dickinson L, Punwani S, Pashayan N, Emberton M, Moore CM, Orczyk C. Stavrinides V, et al. Among authors: fiard g. Eur Urol Focus. 2023 Sep;9(5):781-787. doi: 10.1016/j.euf.2023.03.011. Epub 2023 Apr 6. Eur Urol Focus. 2023. PMID: 37031096 Free article.
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance.
Ploussard G, Roubaud G, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Renard-Penna R, Rozet F, Ruffion A, Sargos P, Mathieu R, Rouprêt M; Comité de Cancérologie de l’Association française d’Urologie, groupe prostate. Ploussard G, et al. Among authors: fiard g. Prog Urol. 2022 Nov;32(15):1373-1419. doi: 10.1016/j.purol.2022.07.147. Prog Urol. 2022. PMID: 36400484 Review.
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.
MacLennan S, Azevedo N, Duncan E, Dunsmore J, Fullwood L, Lumen N, Plass K, Ribal MJ, Roobol MJ, Nieboer D, Schouten N, Skolarus TA, Smith EJ, N'Dow J, Mottet N, Briganti A; Pan-European National Urological Society IMAGINE Collaborative (see Supplemental material for group members affiliations):. MacLennan S, et al. Eur Urol. 2023 May;83(5):393-401. doi: 10.1016/j.eururo.2022.12.031. Epub 2023 Jan 11. Eur Urol. 2023. PMID: 36639296 Free article.
Early discharge in selected patients with low-grade renal trauma.
Freton L, Scailteux LM, Hutin M, Olivier J, Langouet Q, Ruggiero M, Dominique I, Millet C, Bergerat S, Panayatopoulos P, Betari R, Matillon X, Chebbi A, Caes T, Patard PM, Szabla N, Brichart N, Boehm A, Sabourin L, Guleryuz K, Dariane C, Lebacle C, Rizk J, Gryn A, Madec FX, Nouhaud FX, Rod X, Oger E, Fiard G, Bensalah K, Pradere B, Peyronnet B; TRAUMAFUF Collaborative Group. Freton L, et al. Among authors: fiard g. World J Urol. 2020 Apr;38(4):1009-1015. doi: 10.1007/s00345-019-02855-y. Epub 2019 Jun 28. World J Urol. 2020. PMID: 31254097 Free article.
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Baudewyns A, Guenzel K, Halinski A, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Jabbour T, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Zahr RA, Ploussard G, Fiard G, Rysankova K, Bui AP, Taha F, Windisch O, Benamran D, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A, Diamand R. Baudewyns A, et al. Among authors: fiard g. World J Urol. 2024 May 15;42(1):322. doi: 10.1007/s00345-024-04962-x. World J Urol. 2024. PMID: 38747982
Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study).
Branger N, Doumerc N, Waeckel T, Bigot P, Surlemont L, Knipper S, Pignot G, Audenet F, Bruyère F, Fontenil A, Parier B, Champy C, Rouprêt M, Patard JJ, Henon F, Fiard G, Guillotreau J, Beauval JB, Michel C, Bernardeau S, Taha F, Mallet R, Panthier F, Guy L, Vignot L, Khene ZE, Bernhard JC. Branger N, et al. Among authors: fiard g. Eur Urol Open Sci. 2024 Mar 28;63:89-95. doi: 10.1016/j.euros.2024.03.009. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38585592 Free PMC article.
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Diamand R, Guenzel K, Mjaess G, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Benijts J, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Among authors: fiard g. Eur Urol Focus. 2024 Mar 19:S2405-4569(24)00047-6. doi: 10.1016/j.euf.2024.03.003. Online ahead of print. Eur Urol Focus. 2024. PMID: 38508895
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Baboudjian M, Diamand R, Uleri A, Beauval JB, Touzani A, Roche JB, Lacetera V, Roumeguère T, Simone G, Benamran D, Fourcade A, Gondran-Tellier B, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: fiard g. Eur Urol. 2024 Mar 16:S0302-2838(24)00071-X. doi: 10.1016/j.eururo.2024.02.003. Online ahead of print. Eur Urol. 2024. PMID: 38494379
159 results